Category
CLSI C43-A2 – Gas Chromatography/Mass Spectrometry Confirmation of Drugs; Approved Guideline-Second Edition, C43A2E
This archived document is no longer being reviewed through the CLSI Consensus Document Development Process. However, this document is technically valid as of September 2016. Because of its value to the laboratory community, it is being retained in CLSI’s library.
This document provides guidance on establishing uniform practices necessary to produce quality data for quantitation and identification of a drug or drug metabolite using the gas chromatography/mass spectrometry method. Specific quality assurance criteria for maintaining and documenting optimal instrument performance are also presented.
Product Details
- Published:
- 03/01/2010
- ISBN(s):
- 1562387200
- File Size:
- 1 file , 2 MB
- Note:
- This product is unavailable in Russia, Belarus
Related products
-
CLSI VET04
$180.00$108.00Add to cartPerformance Standards for Antimicrobial Susceptibility Testing of Bacteria Isolated From Aquatic Animals, 3rd Edition, VET04Ed3E
Published by Publication Date Number of Pages CLSI 05/20/2020 88 -
CLSI X03R
$180.00$108.00Add to cartImplementing a Needlestick and Sharps Injury Prevention Program in the Clinical Laboratory, X03-R
Published by Publication Date Number of Pages CLSI 03/01/2002 35 -
CLSI QMS26
$180.00$108.00Add to cartManaging Laboratory Records, 1st Edition, QMS26Ed1E
Published by Publication Date Number of Pages CLSI 04/14/2021 80 -
CLSI VET03-A PK (R2018)
$180.00$108.00Add to cartMethods for Antimicrobial Disk Susceptibility Testing of Bacteria Isolated From Aquatic Animals; Approved Guideline , VET03AE; Performance Standards for Antimicrobial Susceptibility Testing of Bacteria Isolated From Aquatic Animals; Second Informational Supplement, VET03VET04S2E
Published by Publication Date Number of Pages CLSI 09/01/2014 0